Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Proteins in Global Oncology Market Driven by Increase in the Prevalence of Cancer and Rising Awareness

Press release Description

Albany, New York, April 12, 2017: Market Research Reports Search Engine (MRRSE) has recently added a new research report to its ever-expanding collection of market intelligence on its global industry verticals involved with Proteins in Global Oncology Market. This latest report is titled as “Proteins in Oncology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2023”. It is an in-depth dissection of facts, figures and factors pertaining to this industry.

As per the key findings of the report, cancer is one of the major causes of death across the globe and finding cure or control for cancer is one of the primary goals of governments, companies and researchers globally. Oncology is the branch of medical studies that deals with cancer treatment and research. The focus of this report is a new treatment method for the usage of proteins as recombinant drugs. Though, surgical procedures and radiation therapies are somewhat effective at curing primary tumors, but they are not successful in detecting tumor cells, making treatment of cancer very complex. Some proteins, on the other hand can be used for diagnostic purposes. There are several research institutes and universities working to identify unique proteins that can play an important role in cancer treatment.

This report on proteins in global oncology market offers an all-inclusive evaluation of this market. It includes an in-depth insight into historical data with a market forecast during the period of 2016 – 2023. The predictions included in the report have been calculated using proven research methodologies and assumptions. The research report also serves as a repository of investigation for every facet of this industry. The report has been compiled through exhaustive primary research (surveys, interviews and observations of industry analysts) and secondary research (trade journals, company reports, industry body databases and other paid sources). It also provides a qualitative and quantitative assessment by analyzing data gathered from industry insiders and market participants across different factors in the industrial value chain mechanism. A thorough analysis of current trends in the parent market, regulations, macro- and micro-economic indicators and mandates is covered within the purview of the study.

The proteins in global oncology market have been segregated based on geographical regions and protein type. Major protein types include the following segments:

  • Recombinant Non-Glycosylated Proteins
  • Recombinant Glycosylated Proteins
  • Recombinant Peptides

Geographically, North America and Europe dominates the global proteins oncology market thanks to the very strict regulatory policies of clearing the products. However, Asia Pacific countries like China and India are estimated to be one of the fastest growing regions.

The key companies contributing to the global proteins oncology market are Actavis Inc., Biocon Ltd., Celltrion Inc., Emcure Pharmaceuticals Ltd., Hospira Inc., Dr. Reddys Laboratories Ltd., Merck, Mylan Inc., Sandoz, Teva Pharmaceuticals, Roche Holding Ltd. and Wockhardt Ltd. Details such as market shares and strategies of these companies are included in the report.

Browse Full Global Oncology Market Report with TOC :

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559